Listeriolysin O As a Strong Immunogenic Molecule for the Development of New Anti-tumor Vaccines

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2013 Feb 13

PMID 23399758

Citations 13

Authors

Rui Sun

Yuqin Liu

Affiliations

Soon will be listed here.

Abstract

The pore-forming toxin listeriolysin O (LLO), which is produced by Listeria monocytogenes, mediates bacterial phagosomal escape and facilitates bacterial multiplication during infection. This toxin has recently gained attention because of its confirmed role in the controlled and specific modulation of the immune response. Currently, cancer immunotherapies are focused on conquering the immune tolerance induced by poorly immunogenic tumor antigens and eliciting strong, lasting immunological memory. An effective way to achieve these goals is the co-administration of potent immunomodulatory adjuvant components with vaccine vectors. LLO, a toxin that belongs to the family of cholesterol-dependent cytolysins (CDCs), exhibits potent cell type-non-specific toxicity and is a source of dominant CD4(+) and CD8(+) T cell epitopes. According to recent research, in addition to its effective cytotoxicity as a cancer immunotherapeutic drug, the non-specific adjuvant property of LLO makes it promising for the development of efficacious anti-tumor vaccines.

Citing Articles

Exploiting bacteria for cancer immunotherapy.

Kwon S, Ngo H, Son J, Hong Y, Min J Nat Rev Clin Oncol. 2024; 21(8):569-589.

PMID: 38840029 DOI: 10.1038/s41571-024-00908-9.

Cytotoxic Activity of LLO Y406A Is Targeted to the Plasma Membrane of Cancer Urothelial Cells.

Resnik N, Tratnjek L, Kreft M, Kisovec M, Aden S, Bedina Zavec A Int J Mol Sci. 2021; 22(7).

PMID: 33805017 PMC: 8037347. DOI: 10.3390/ijms22073305.

ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer.

Galicia-Carmona T, Arango-Bravo E, Serrano-Olvera J, Flores-de La Torre C, Cruz-Esquivel I, Villalobos-Valencia R Hum Vaccin Immunother. 2021; 17(8):2617-2625.

PMID: 33793380 PMC: 8475562. DOI: 10.1080/21645515.2021.1893036.

Lipid larceny: channelizing host lipids for establishing successful pathogenesis by bacteria.

Chatterjee R, Roy Chowdhury A, Mukherjee D, Chakravortty D Virulence. 2020; 12(1):195-216.

PMID: 33356849 PMC: 7808437. DOI: 10.1080/21505594.2020.1869441.

A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.

Phelps C, Vadia S, Boyaka P, Varikuti S, Attia Z, Dubey P Vaccine. 2020; 38(36):5803-5813.

PMID: 32684498 PMC: 7788512. DOI: 10.1016/j.vaccine.2020.06.049.

References

Jones S, Portnoy D . Characterization of Listeria monocytogenes pathogenesis in a strain expressing perfringolysin O in place of listeriolysin O. Infect Immun. 1994; 62(12):5608-13. PMC: 303309. DOI: 10.1128/iai.62.12.5608-5613.1994. View

Weiglein I, Goebel W, Troppmair J, Rapp U, Demuth A, Kuhn M . Listeria monocytogenes infection of HeLa cells results in listeriolysin O-mediated transient activation of the Raf-MEK-MAP kinase pathway. FEMS Microbiol Lett. 1997; 148(2):189-95. DOI: 10.1111/j.1574-6968.1997.tb10287.x. View

Carter P . Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer. 2002; 1(2):118-29. DOI: 10.1038/35101072. View

Bruhn K, Craft N, Miller J . Listeria as a vaccine vector. Microbes Infect. 2007; 9(10):1226-35. DOI: 10.1016/j.micinf.2007.05.010. View

Rescigno M, Citterio S, Thery C, Rittig M, Medaglini D, Pozzi G . Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A. 1998; 95(9):5229-34. PMC: 20243. DOI: 10.1073/pnas.95.9.5229. View

Shepard L, Shatursky O, Johnson A, Tweten R . The mechanism of pore assembly for a cholesterol-dependent cytolysin: formation of a large prepore complex precedes the insertion of the transmembrane beta-hairpins. Biochemistry. 2000; 39(33):10284-93. DOI: 10.1021/bi000436r. View

Los F, Kao C, Smitham J, McDonald K, Ha C, Peixoto C . RAB-5- and RAB-11-dependent vesicle-trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin. Cell Host Microbe. 2011; 9(2):147-57. PMC: 3057397. DOI: 10.1016/j.chom.2011.01.005. View

Wipke B, Jameson S, Bevan M, Pamer E . Variable binding affinities of listeriolysin O peptides for the H-2Kd class I molecule. Eur J Immunol. 1993; 23(8):2005-10. DOI: 10.1002/eji.1830230842. View

Pamer E, Sijts A, Villanueva M, Busch D, Vijh S . MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses. Immunol Rev. 1997; 158:129-36. DOI: 10.1111/j.1600-065x.1997.tb00999.x. View

10.

Pamer E, Harty J, Bevan M . Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature. 1991; 353(6347):852-5. PMC: 2782917. DOI: 10.1038/353852a0. View

11.

Villanueva M, Sijts A, Pamer E . Listeriolysin is processed efficiently into an MHC class I-associated epitope in Listeria monocytogenes-infected cells. J Immunol. 1995; 155(11):5227-33. View

12.

Slingerland M, Guchelaar H, Gelderblom H . Liposomal drug formulations in cancer therapy: 15 years along the road. Drug Discov Today. 2011; 17(3-4):160-6. DOI: 10.1016/j.drudis.2011.09.015. View

13.

Peng X, Hussain S, Paterson Y . The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function. J Immunol. 2004; 172(10):6030-8. DOI: 10.4049/jimmunol.172.10.6030. View

14.

Alexandroff A, Jackson A, ODonnell M, JAMES K . BCG immunotherapy of bladder cancer: 20 years on. Lancet. 1999; 353(9165):1689-94. DOI: 10.1016/S0140-6736(98)07422-4. View

15.

Neeson P, Pan Z, Paterson Y . Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma. Cancer Immunol Immunother. 2007; 57(4):493-505. PMC: 11030947. DOI: 10.1007/s00262-007-0388-y. View

16.

Soltani C, Hotze E, Johnson A, Tweten R . Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions. Proc Natl Acad Sci U S A. 2007; 104(51):20226-31. PMC: 2154413. DOI: 10.1073/pnas.0708104105. View

17.

Wallecha A, Wood L, Pan Z, Maciag P, Shahabi V, Paterson Y . Listeria monocytogenes-derived listeriolysin O has pathogen-associated molecular pattern-like properties independent of its hemolytic ability. Clin Vaccine Immunol. 2012; 20(1):77-84. PMC: 3535771. DOI: 10.1128/CVI.00488-12. View

18.

Polekhina G, Giddings K, Tweten R, Parker M . Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin. Proc Natl Acad Sci U S A. 2005; 102(3):600-5. PMC: 545513. DOI: 10.1073/pnas.0403229101. View

19.

Idone V, Tam C, Andrews N . Two-way traffic on the road to plasma membrane repair. Trends Cell Biol. 2008; 18(11):552-9. PMC: 2593466. DOI: 10.1016/j.tcb.2008.09.001. View

20.

Gaillard J, Berche P, Frehel C, Gouin E, Cossart P . Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive cocci. Cell. 1991; 65(7):1127-41. DOI: 10.1016/0092-8674(91)90009-n. View